Non-invasive prenatal testing (NIPT) is a simple blood test during pregnancy that helps detect rare genetic conditions early, ...

Methods developed and validated to establish the “World Bank of NK Cells” from healthy donors and cancer patientsSingle ...

To address the demand for rapid, highly specific therapeutic candidates, Creative Biolabs has optimized its comprehensive ...

U.S. Gene Expression Analysis Market size is USD 1.28 Billion in 2025 and is expected to reach USD 2.45 Billion by 2035 owing to high penetration of advanced molecular analysis technologies.Austin, ...

Microliter dispensing pumps deliver accurate low-volume dosing to support laboratory, diagnostic, and industrial fluid ...

A significant proportion of repeated pregnancy failures can be attributed to chromosomal abnormalities—either inherited from one of the parents or arising spontaneously in the embryo.

Detailed price information for Bionano Genomics Inc (BNGO-Q) from The Globe and Mail including charting and trades.

The statistical interaction between genetic susceptibility and lifestyle was significant in the larger cohort and showed similar directional trends in the Indian cohort, according to the study.

A strategic partnership between Vaxxas and Profenso, an Australian AI company specialising in advanced automation for regulated industries, has been announced.

Molecular profiling of tumors has been shown to improve risk stratification, and it may be useful for prostate cancer active surveillance.

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Illumina (NASDAQ:ILMN) and its peers.

The panel ensures compatibility with our previous autosomal Family Finder tests plus all the autosomal transfers we ...